These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29846534)

  • 21. Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022.
    Brenner BG; Ibanescu RI; Oliveira M; Margaillan G; Lebouché B; Thomas R; Baril JG; Lorgeoux RP; Roger M; Routy JP; The Montreal Primary Hiv Infection Phi Cohort Study Group
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.
    Rhee SY; Tzou PL; Shafer RW
    Viruses; 2021 May; 13(5):. PubMed ID: 34064774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020-2023.
    Zhang T; Dou H; Ye H; Tang H; Wang W; Hu W; Lv B; Zhou M; Dai H; Wang W; Sun B
    Virol J; 2024 Oct; 21(1):257. PubMed ID: 39420358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.
    Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A
    Antivir Ther; 2014; 19(8):813-8. PubMed ID: 24699043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of Transmitted Drug Resistance and Virological Response to First-line Antiretroviral Treatment Among Human Immunodeficiency Virus-Infected People Who Use Illicit Drugs in a Canadian Setting.
    Socías ME; Nosova E; Kerr T; Hayashi K; Harrigan PR; Shoveller J; Montaner J; Milloy MJ
    Clin Infect Dis; 2017 Sep; 65(5):796-802. PubMed ID: 28482025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates.
    Rhee SY; Kassaye SG; Barrow G; Sundaramurthi JC; Jordan MR; Shafer RW
    J Int AIDS Soc; 2020 Sep; 23(9):e25611. PubMed ID: 32936523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
    Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
    PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
    Yang WL; Kouyos R; Scherrer AU; Böni J; Shah C; Yerly S; Klimkait T; Aubert V; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Held L; Ledergerber B; Günthard HF;
    J Infect Dis; 2015 Jul; 212(1):28-38. PubMed ID: 25576600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.
    Hamers RL; Siwale M; Wallis CL; Labib M; van Hasselt R; Stevens WS; Schuurman R; Wensing AM; Van Vugt M; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):95-101. PubMed ID: 20585262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
    Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
    Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.
    Wang X; Liu X; Li F; Zhou H; Li J; Wang Y; Liu L; Liu S; Feng Y; Wang N
    PLoS One; 2018; 13(6):e0198005. PubMed ID: 29870534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan.
    Weng YW; Chen IT; Tsai HC; Wu KS; Tseng YT; Sy CL; Chen JK; Lee SS; Chen YS
    BMC Infect Dis; 2019 Aug; 19(1):741. PubMed ID: 31443633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of drug-resistant HIV type 1 at the time of initiation of antiretroviral therapy in Portland, Oregon.
    MacVeigh MS; Kosmetatos MK; McDonald JE; Reeder JL; Parrish DA; Young TP
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):337-42. PubMed ID: 22697610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden.
    Andersson E; Nordquist A; Esbjörnsson J; Flamholc L; Gisslén M; Hejdeman B; Marrone G; Norrgren H; Svedhem V; Wendahl S; Albert J; Sönnerborg A
    AIDS; 2018 Apr; 32(7):877-884. PubMed ID: 29369826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
    Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran.
    Memarnejadian A; Nikpoor AR; Davoodian N; Kargar A; Mirzadeh Y; Gouklani H
    Intervirology; 2019; 62(2):72-79. PubMed ID: 31311021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
    Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.